Invasive beta-haemolytic streptococcal infections, Finland, 2006 to 2020: increase in Lancefield group C/G infections
: Paspaliari Dafni Katarina, Sarvikivi Emmi, Ollgren Jukka, Vuopio Jaana
Publisher: European Centre for Disease Prevention and Control (ECDC)
: 2023
: Eurosurveillance
: Eurosurveillance
: 28
: 31
DOI: https://doi.org/10.2807/1560-7917.ES.2023.28.31.2200807(external)
: https://doi.org/10.2807/1560-7917.ES.2023.28.31.2200807
: https://research.utu.fi/converis/portal/detail/Publication/180913518(external)
Background: Invasive infections with beta-haemolytic streptococci of Lancefield groups A (iGAS), B (iGBS) and C/G (iGCGS) are a major cause of morbidity and mortality worldwide.
Aim: We studied incidence trends of invasive beta-haemolytic streptococcal infections in Finland, focusing on iGCGS. Methods: We conducted a retrospective register-based study. Cases were defined as isolations from blood and/or cerebrospinal fluid and retrieved from the National Infectious Disease Register where all invasive cases are mandatorily notified.
Results: Between 2006 and 2020, the mean annual incidence was 4.1 per 100,000 for iGAS (range: 2.1- 6.7), 5.2 for iGBS (4.0-6.3) and 10.1 for iGCGS (5.4- 17.6). The incidence displayed an increasing trend for all groups, albeit for iGBS only for individuals 45 years and older. The increase was particularly sharp for iGCGS (8% annual relative increase). The incidence rate was higher in males for iGCGS (adjusted incidence rate ratio (IRR) = 1.6; 95% confidence interval (CI): 1.5- 1.8) and iGAS (adjusted IRR = 1.3; 95% CI: 1.1-1.4); for iGBS, the association with sex was age-dependent. In adults, iGCGS incidence increased significantly with age. Recurrency was seen for iGCGS and secondarily iGBS, but not for iGAS. Infections with iGCGS and iGBS peaked in July and August.
Conclusions: The incidence of invasive beta-haemolytic streptococcal infections in Finland has been rising since 2006, especially for iGCGS and among the elderly population. However, national surveillance still focuses on iGAS and iGBS, and European Union-wide surveillance is lacking. We recommend that surveillance of iGCGS be enhanced, including systematic collection and typing of isolates, to guide infection prevention strategies